MANAGEMENT OF DIABETIC RETINOPATHY, PREVALENCE AND CLINICAL CLASSIFICATION.

Abstract

AIMS:

To ascertain the prevalence of diabetic retinopathy--DR, based on the duration of the diabetes mellitus--DM and to compare it with data from relevant literature and other referent clinics.

MATERIAL AND METHODS:

In this study are included the patients with diabetes mellitus type 1 insulin-dependent--DMID and diabetes mellitus type 2 non-insulin-dependent--DMNID. The duration of diabetes in the examined patients varied from 5 till 30 years. We have applied examination by ophthalmoscope, slit lamp bio-microscopy with Volk and Goldman lens, optical coherence tomography--OCT as well as fluorescein angiography--FAG. Have been included the treated patients with DR, from September 2004-2014.

RESULTS:

In diabetic patients suffering for a period of 5 years, the prevalence of DR is 10%. In diabetic patients suffering over 30 years, the prevalence of DR is varied from 82% until 97%.

CONCLUSION:

Diabetic retinopathy, undertakes a multidisciplinary approach in all patients with diabetes to achieve optimal blood glucose control HbA1c levels 7.0% or lower and to adequately manage systolic blood pressure less than 140 mmHg and serum LDL cholesterol of less than 2.5 mmol/L and triglycerides of less than 2.0 mmol/L. Always should be assessed visual acuity at the time of DR examination.

• Authors: Alil Ajvazi, Pajtim Lutaj, Ilhami Goranci
• Journal: Oftalmologia (Bucharest, Romania : 1990) (Oftalmologia) Vol. 58 Issue 4 Pg. 47-50 ( 2014) ISSN: 1220-0875 [Print] Romania
• PMID: 26117931 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Biomarkers
• Cholesterol, LDL
• Glycated Hemoglobin A
• Hypoglycemic Agents
• Triglycerides

Topics

• Biomarkers (blood)
• Blood Pressure
• Cholesterol, LDL (blood)
• Diabetes Mellitus, Type 1 (blood, complications, drug therapy, epidemiology)
• Diabetes Mellitus, Type 2 (blood, complications, drug therapy, epidemiology)
• Diabetic Retinopathy (classification, diagnosis, epidemiology, etiology, prevention & control)
• Glycated Hemoglobin (metabolism)
• Humans
• Hypoglycemic Agents (therapeutic use)
• Prevalence
• Risk Factors
• Romania (epidemiology)
• Severity of Illness Index
• Time Factors
• Triglycerides (blood)
• Visual Acuity